SCHEMBL7224995

SCHEMBL7224995

Nc1ccc(Sc2ccc(C(=O)N[C@@H]3C[C@H]4CC[C@@H]3N4)s2)cc1

nearest known ligand 0.34

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 2/20 0.34
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 2/20 0.33
ALDH1A1 P00352 1/20 0.30
HPGD P15428 1/20 0.30
DDB1 Q16531 1/20 0.30
CRBN Q96SW2 1/20 0.30
IKZF3 Q9UKT9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7231963 0.91 ESR1 (0.37) CHRNA7SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL7231256 0.90 CHRNB2 (0.35) CHRNA7SLC6A2SLC6A4SLC6A3
SCHEMBL7234021 0.89 SLC6A3 (0.39) CHRNA7SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL7232207 0.89 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3HPGD
SCHEMBL7231965 0.89 CHRNA7 (0.36) CHRNA7
Hydrochloric Acid SCHEMBL7231366 0.88 SLC6A3 (0.38) CHRNA7SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL7230208 0.88 CHRNB2 (0.34) SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL7231554 0.88 HSD17B1 (0.37) CHRNA7SLC6A2SLC6A4SLC6A3
SCHEMBL7233055 0.88 HPGD (0.36) CHRNA7SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL7232565 0.88 EPHX2 (0.35) CHRNA7SLC6A2SLC6A4SLC6A3DDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562816-B2 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects PHARMACIA & UPJOHN COMPANY 2003-05-13 US claimed
US-6562816-B2 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects PHARMACIA & UPJOHN COMPANY 2003-05-13 US disclosed